All lobbying filings

Kelley Drye & Warren LLP

Kelley Drye & Warren LLP filed a Q2 report for Partnership to End HIV, AIDS & Hepatitis on July 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Partnership to End HIV, AIDS & Hepatitis · Coalition of non-profit organizations supporting funding and access to HIV/AIDS treatments

As filed: KELLEY DRYE & WARREN LLP for PARTNERSHIP TO END HIV, AIDS & HEPATITIS.

All filings by Kelley Drye & Warren LLP · Everything Partnership to End HIV, AIDS & Hepatitis has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.

Bills named in this filing 2

H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
H.R. 9170
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.